Role of reactive oxygen species in Kv channel inhibition and vasoconstriction induced by TP receptor activation in rat pulmonary arteries

Annals of the New York Academy of Sciences

Volumn 1091, Issue , 2006, Pages 41-51

  Cogolludo, Angel ^a   Frazziano, Giovanna ^a   Cobeño, Laura ^a   Moreno, Laura ^a   Lodi, Federica ^a   Villamor, Eduardo ^b   Tamargo, Juan ^a   Perez Vizcaino, Francisco ^a  

^a SCHOOL OF MEDICINE   (Spain)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cyclooxygenases; Thromboxane A2; Voltage gated potassium channels

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; APOCYNIN; CATALASE; DICHLOROFLUORESCEIN; DIPHENYLIODONIUM SALT; ENDOPEROXIDE; HYDROGEN PEROXIDE; MACROGOL; REACTIVE OXYGEN METABOLITE; TERT BUTYL HYDROPEROXIDE; THROMBOXANE RECEPTOR; VOLTAGE GATED POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; THROMBOXANE A2 RECEPTOR; VASOCONSTRICTOR AGENT;

ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME INHIBITION; MALE; MEMBRANE PERMEABILITY; NONHUMAN; PULMONARY ARTERY; RAT; VASOCONSTRICTION; ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; WISTAR RAT;

RATTUS;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; MALE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, VOLTAGE-GATED; PULMONARY ARTERY; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; SIGNAL TRANSDUCTION; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 33947602453     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1378.053     Document Type: Conference Paper

References (29)

1. BABER, S.R. et al. 2003. Role of cyclooxygenase-2 in the generation of vasoactive prostanoids in the rat pulmonary and systemic vascular beds. Circulation 108: 896-901.
2. JANSSEN, L.J. 2001. Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am. J. Physiol. 280: L1067-L1082.
3. 2 mimetic U46619. Br. J. Pharmacol. 121: 1323-1333.
4. GONZALEZ-LUIS, G. et al 2005. Age-related differences in vasoconstrictor responses to isoprostanes in piglet pulmonary and mesenteric vascular smooth muscle. Pediatr. Res. 57: 845-852.
5. CHRISTMAN, B.W. et al. 1992. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N. Engl. J. Med. 327: 70-75.
6. MONTALESCOT, G. et al. 1990. Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep. Circulation 82: 1765-1777.
7. + channels, Kv1.5 and Kv1.2, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes. J. Clin. Invest. 101: 2319-2330.
8. 2+]i in pulmonary arterial myocytes. Circ. Res. 77: 370-378.
9. + channel gene transcription in primary pulmonary hypertension. Lancet 351: 726-727.
10. ARCHER, S. & S. RICH. 2000. Primary pulmonary hypertension: a vascular biology and translational research "work in progress." Circulation 102: 2781-2791.
11. + channels in human pulmonary artery smooth muscle cells. Lancet 352: 290.
12. + channels and pulmonary vasoconstriction. Role of protein kinase Cζ. Circ. Res. 93: 656-663.
13. + channels to RhoA/Rho kinase in pulmonary vasoconstriction. Cardiovasc. Res. 66: 84-93.
14. CAI, H. & D.G. HARRISON. 2000. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87: 840-844.
15. TOUYZ, R.M. et al. 2004. Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. J. Hypertens. 22: 1141-1149.
16. GRIENDLING, K.K. & M. USHIO-FUKAI. 2000. Reactive oxygen species as mediators of angiotensin II signaling. Regul. Pept. 91: 21-27.
17. LI, L. et al. 2003. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Circulation 107: 1053-1058.
18. LIU, Y. & D.D. GUTTERMAN. 2002. Oxidative stress and potassium channel function. Clin. Exp. Pharmacol. Physiol. 29: 305-311.
19. + channels in smooth muscle cells by a mitochondrial redox sensor. Circ. Res. 91: 478-486.
20. + channel current in rat small coronary arteries. Circ. Res. 89: 146-152.
21. GRIENDLING, K.K., D. SORESCU & M. USHIO-FUKAI. 2000. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86: 494-501.
22. SOUZA, H.P. et al. 2001. Vascular NAD(P)H oxidase is distinct from the phagocytic enzyme and modulates vascular reactivity control. Am. J. Physiol. Heart Circ. Physiol. 280: H658-H667.
23. PEREZ-VIZCAINO, F. et al. 2002. Postnatal maturation in nitric oxide-induced pulmonary artery relaxation involving cyclooxygenase-1 activity. Am. J. Physiol. Lung Cell. Mol. Physiol. 283: L839-L848.
24. MYHRE, O. et al. 2003. Evaluation of the probes 2,7-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation. Biochem. Pharmacol. 65: 1575-1582.
25. 2α, cytokines and endotoxin in the pig pulmonary artery. Br. J. Pharmacol. 141: 488-496.
26. CHLOPICKI, S. et al. 2004. Functional role of NADPH oxidase in activation of platelets. Antioxid. Redox Signal. 6: 691-698.
27. DADA, L.A. et al. 2003. Hypoxia-induced endocytosis of Na,K-ATPase in alveolar epithelial cells is mediated by mitochondrial reactive oxygen species and PKC-zeta. J. Clin. Invest. 111: 1057-1064.
28. 2. Proc. Natl. Acad. Sci. USA 94: 11233-11237.
29. LUCCHESI, P.A. et al. 2005. Hydrogen peroxide acts as both vasodilator and vasoconstrictor in the control of perfused mouse mesenteric resistance arteries. J. Hypertens. 23: 571-579.